Price range: $150.00 through $250.00
Name: AOD 9604 acetate; Frag 176-191 Oxidized;
CAS No.: 221231-10-3
Peptide Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Disulfide bridge Cys7-Cys15)
Molecular Formula: C78H123N23O23S2
Molecular Weight: 1815.1
Appearance: White Lyophilized powder
AOD‑9604 is a synthetic peptide derived from the C-terminal end of the human growth hormone (HGH) molecule, specifically the amino acid sequence 176–191. Unlike full-length HGH, which affects growth and metabolism broadly, AOD‑9604 was engineered to target fat metabolism specifically — without the side effects associated with growth hormone therapy.
Originally developed for obesity research, this peptide has drawn attention in wellness and performance communities for its potential fat-burning effects, especially in stubborn areas like the abdomen and thighs.
AOD‑9604 mimics the lipolytic (fat-releasing) activity of HGH by stimulating the breakdown of stored fat. This process — known as lipolysis — allows the body to release fatty acids into the bloodstream for use as energy.
In addition to stimulating fat breakdown, AOD‑9604 may help prevent lipogenesis — the formation of new fat cells. It acts on certain metabolic pathways to inhibit enzymes that are essential for fat storage.
Unlike full HGH, AOD‑9604 does not significantly increase levels of insulin-like growth factor 1 (IGF‑1) or disturb glucose regulation. This selectivity means users may gain fat-burning benefits without the insulin resistance or growth-promoting effects of HGH.
While human research is still evolving, anecdotal reports and preliminary studies suggest the following potential benefits:
Users often report fat reduction in stubborn areas, particularly the abdominal region, hips, and thighs.
When combined with exercise and diet, AOD‑9604 may help shift the body’s fat-to-muscle ratio, promoting a leaner physique.
Some users notice enhanced energy levels and metabolic flexibility, allowing for better use of fat as a fuel source.
Emerging data suggests AOD‑9604 may support cartilage repair and joint health, possibly making it helpful for active individuals or athletes.
Disclaimer: These benefits are based on preliminary studies and anecdotal reports. AOD‑9604 is not an FDA-approved treatment for weight loss or metabolic disorders.
AOD‑9604 was originally developed by Metabolic Pharmaceuticals in Australia and underwent multiple clinical trials. Key research findings include:
Early animal studies showed significant fat reduction without changes in blood sugar or growth levels.
In a small human trial, subjects taking AOD‑9604 experienced greater fat loss compared to placebo (up to 2.6 kg over several weeks).
Larger clinical trials failed to show statistically significant weight loss in obese populations, leading to discontinued development as a pharmaceutical.
Despite limited clinical efficacy data, the peptide continues to be explored in wellness and body optimization communities.
AOD‑9604 is commonly administered via subcutaneous injection, typically in the abdominal area to target belly fat. Some newer formats — including oral or topical versions — exist but may have lower bioavailability.
While dosing protocols vary, a common research dosage is 300–500 mcg per day, often taken in the morning or pre-exercise. However, protocols should always be tailored by a licensed healthcare professional.
Cycles may last from 4 to 12 weeks, depending on the goals and supervision. Many users combine AOD‑9604 with other peptides or lifestyle strategies for best results.
USA: AOD‑9604 is not approved by the FDA for therapeutic use. It is sold for research purposes only.
Australia: Approved as an ingredient in topical creams and cosmetics, not for systemic use.
UK & EU: Typically unregulated for cosmetic or research use, but cannot be marketed as a medical product without authorization.
⚠️ Always check local regulations and consult a healthcare provider before considering any peptide.
In most studies, AOD‑9604 appears to be well-tolerated. Reported side effects are mild and may include:
Injection site redness or swelling
Temporary fatigue
Headache
Mild dizziness
Long-term safety studies in humans are lacking. Like many peptides in research stages, AOD‑9604 should be approached with caution and used under medical supervision where applicable.
| Peptide | Mechanism | Common Use | IGF‑1 Elevation | Appetite Suppression |
|---|---|---|---|---|
| AOD‑9604 | Lipolysis, anti-lipogenesis | Fat loss | ❌ No | ❌ No |
| CJC‑1295 | Growth hormone releasing | Muscle + fat loss | ✅ Yes | ❌ No |
| Semaglutide | GLP‑1 receptor agonist | Weight loss, diabetes | ❌ No | ✅ Yes |
| Tesamorelin | GHRH analog, reduces VAT | Visceral fat reduction | ✅ Yes | ❌ No |
If you’re considering AOD‑9604 as part of a wellness protocol, keep the following tips in mind:
✅ Use reputable sources – Ensure your peptide is third-party tested, sterile, and free of contaminants.
✅ Combine with exercise & nutrition – Fat-burning peptides work best when paired with a calorie-conscious, macro-balanced diet and regular physical activity.
✅ Track body composition – Use DEXA scans or calipers rather than relying on scale weight alone.
✅ Monitor progress & labs – Especially if you’re under medical care, track metabolic markers and side effects.
❌ Don’t self-medicate – Using experimental peptides without supervision carries real risks.
Yes — but only for research use. It’s not approved for medical treatment or weight loss under FDA guidelines.
Not directly. It doesn’t stimulate IGF‑1 or growth hormone release, so it won’t promote muscle growth like other peptides (e.g., CJC‑1295).
Some users report changes in 2–4 weeks, but results vary and depend on dosage, diet, exercise, and individual factors.
Yes — it’s often stacked with peptides like CJC‑1295, Ipamorelin, or BPC‑157. However, stacking should only be done with professional guidance.
AOD‑9604 is an exciting development in the world of peptide-based fat loss, offering a more targeted and possibly safer alternative to full growth hormone therapy. While the science is still evolving and long-term effects remain uncertain, its selective fat-burning potential makes it a popular topic in biohacking and performance circles.
That said, it’s essential to approach AOD‑9604 with realistic expectations, use proper sourcing, and integrate it into a balanced lifestyle strategy — not as a “magic bullet.”
If you’re considering AOD‑9604, consult a licensed health professional, especially one experienced in peptide therapy or functional medicine.
